Inspira Technologies OXY B.H.N. (IINN) Competitors $1.41 -0.02 (-1.40%) Closing price 04:00 PM EasternExtended Trading$1.40 -0.01 (-0.71%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IINN vs. CTSO, HYPR, SURG, ICCM, RBOT, EDAP, CTCX, ECOR, APT, and MLSSShould you be buying Inspira Technologies OXY B.H.N. stock or one of its competitors? The main competitors of Inspira Technologies OXY B.H.N. include Cytosorbents (CTSO), Hyperfine (HYPR), SurgePays (SURG), IceCure Medical (ICCM), Vicarious Surgical (RBOT), Edap Tms (EDAP), Carmell (CTCX), electroCore (ECOR), Alpha Pro Tech (APT), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry. Inspira Technologies OXY B.H.N. vs. Its Competitors Cytosorbents Hyperfine SurgePays IceCure Medical Vicarious Surgical Edap Tms Carmell electroCore Alpha Pro Tech Milestone Scientific Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership. Which has better earnings and valuation, IINN or CTSO? Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Cytosorbents. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspira Technologies OXY B.H.N.N/AN/A-$11.05MN/AN/ACytosorbents$35.60M1.66-$20.72M-$0.28-3.37 Do institutionals and insiders hold more shares of IINN or CTSO? 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 32.9% of Cytosorbents shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 7.3% of Cytosorbents shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is IINN or CTSO more profitable? Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Cytosorbents' net margin of -41.77%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Cytosorbents' return on equity.Company Net Margins Return on Equity Return on Assets Inspira Technologies OXY B.H.N.N/A N/A N/A Cytosorbents -41.77%-105.04%-29.18% Does the media prefer IINN or CTSO? In the previous week, Cytosorbents had 5 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 6 mentions for Cytosorbents and 1 mentions for Inspira Technologies OXY B.H.N.. Cytosorbents' average media sentiment score of 0.69 beat Inspira Technologies OXY B.H.N.'s score of 0.62 indicating that Cytosorbents is being referred to more favorably in the news media. Company Overall Sentiment Inspira Technologies OXY B.H.N. Positive Cytosorbents Positive Do analysts recommend IINN or CTSO? Inspira Technologies OXY B.H.N. currently has a consensus target price of $2.00, suggesting a potential upside of 41.84%. Cytosorbents has a consensus target price of $5.50, suggesting a potential upside of 482.87%. Given Cytosorbents' higher probable upside, analysts clearly believe Cytosorbents is more favorable than Inspira Technologies OXY B.H.N..Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Cytosorbents 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility & risk, IINN or CTSO? Inspira Technologies OXY B.H.N. has a beta of 2.24, indicating that its stock price is 124% more volatile than the S&P 500. Comparatively, Cytosorbents has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. SummaryInspira Technologies OXY B.H.N. and Cytosorbents tied by winning 6 of the 12 factors compared between the two stocks. Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IINN vs. The Competition Export to ExcelMetricInspira Technologies OXY B.H.N.MED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.79M$7.00B$5.74B$9.51BDividend YieldN/A1.28%4.60%3.99%P/E RatioN/A25.5128.1120.03Price / SalesN/A66.31460.63103.88Price / CashN/A20.6736.5559.01Price / Book4.154.758.655.90Net Income-$11.05M$176.14M$3.25B$258.66M7 Day PerformanceN/A2.92%4.20%2.23%1 Month Performance60.26%3.56%10.83%12.77%1 Year Performance33.02%7.66%34.67%19.36% Inspira Technologies OXY B.H.N. Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IINNInspira Technologies OXY B.H.N.2.2303 of 5 stars$1.41-1.4%$2.00+41.8%+31.2%$17.79MN/A0.0020CTSOCytosorbents1.6677 of 5 stars$1.03-1.9%$5.50+434.0%-1.0%$64.49M$35.33M-3.68220Gap UpHYPRHyperfine1.4355 of 5 stars$0.81+0.6%$1.06+31.7%-0.9%$62.66M$11.73M-1.49190News CoveragePositive NewsSURGSurgePays3.1503 of 5 stars$2.95-1.3%$9.00+205.1%-1.9%$60.22M$40.03M-1.0640ICCMIceCure Medical2.3261 of 5 stars$1.01-1.9%$2.50+147.5%+20.1%$59.28M$3.27M-3.6160News CoverageGap UpRBOTVicarious Surgical0.3751 of 5 stars$9.55+4.3%$8.50-10.9%+77.7%$56.61MN/A-0.91210Gap DownHigh Trading VolumeEDAPEdap Tms3.0712 of 5 stars$1.48-1.3%$8.50+472.5%-70.2%$55.52M$62.77M-2.39230Positive NewsGap DownCTCXCarmellN/A$2.65-1.3%N/A+316.0%$55.29M$32.84K0.0014ECORelectroCore3.2738 of 5 stars$6.95-6.7%$25.50+266.9%+21.5%$51.57M$25.18M-4.4650Positive NewsAPTAlpha Pro Tech1.1191 of 5 stars$4.74-1.5%N/A-18.2%$51.50M$58.18M12.81120MLSSMilestone Scientific2.7632 of 5 stars$0.64-1.1%$1.25+94.4%-38.7%$50.46M$8.61M-9.1830Negative News Related Companies and Tools Related Companies CTSO Alternatives HYPR Alternatives SURG Alternatives ICCM Alternatives RBOT Alternatives EDAP Alternatives CTCX Alternatives ECOR Alternatives APT Alternatives MLSS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IINN) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspira Technologies OXY B.H.N. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspira Technologies OXY B.H.N. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.